I would have to listen again, you could be correct with that.
I don’t see why it would take too long to complete the study. Btm and the competitors product are already both FDA approved product. The trial is simply comparing results like Time in bed, elasticity, cosmetic differences, infection rate, take rate, quality of life after recovery etc etc. I have no medical background at all this is just my interpretation.
I know they did mentioned about PMA approval for btm by the end of 2025 CY.
PNV - Chart, page-19492
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.52 |
Change
-0.070(2.70%) |
Mkt cap ! $1.740B | |||
| Open | High | Low | Value | Volume |
| $2.59 | $2.61 | $2.47 | $3.489M | 1.379M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3841 | $2.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.54 | 9238 | 2 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| PNV (ASX) Chart |